What is Tirzepatide, and how does it work?
Tirzepatide is a novel, investigational, once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes and obesity. It represents a significant advancement in the field of metabolic medicine due to its dual action on GIP and GLP-1 receptors, which play crucial roles in glucose and weight regulation.
Tirzepatide works by activating both the GIP and GLP-1 receptors, leading to increased insulin secretion, decreased glucagon secretion, slowed gastric emptying, and reduced appetite. This dual action contributes to improved glycemic control and expedite weight loss.
Anonymous (verified owner) –
Been on these meds since Feb and I love them. Slowly dropping weight and loving the results. I’m still continuing my journey so I will continue to purchase 💜 thanks